Literature DB >> 1693408

Preparation and characterization of neutralizing monoclonal antibodies to feline calicivirus.

Y Tohya1, Y Taniguchi, M Tsubakimoto, E Takahashi, T Mikami.   

Abstract

Fourteen neutralizing monoclonal antibodies (N-MoAbs) were prepared against the F4 strain of feline calicivirus (FCV), the prototype strain of FCV in Japan, and examined for their ability to neutralize FCV isolates. Neutralization-resistant variants of the F4 strain were selected under the presence of 4 individual N-MoAbs in cell culture systems and used in cross-neutralization tests and enzyme-linked immunosorbent assay with all of the 14 N-MoAbs. The results revealed the identification of at least two antigenic determinants on FCV F4: one being more broadly conserved among FCV isolates than the other. Usefulness of antigenic variants resistant to N-MoAbs for analysis of neutralization determinants on FCV was also demonstrated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693408     DOI: 10.1292/jvms1939.52.251

Source DB:  PubMed          Journal:  Nihon Juigaku Zasshi        ISSN: 0021-5295


  5 in total

1.  Antigenic change in feline calicivirus during persistent infection.

Authors:  R P Johnson
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

2.  Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.

Authors:  Tomoyuki Shiota; Michio Okame; Sayaka Takanashi; Pattara Khamrin; Makiko Takagi; Kenji Satou; Yuichi Masuoka; Fumihiro Yagyu; Yuko Shimizu; Hideki Kohno; Masashi Mizuguchi; Shoko Okitsu; Hiroshi Ushijima
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

3.  Recovery and altered neutralization specificities of chimeric viruses containing capsid protein domain exchanges from antigenically distinct strains of feline calicivirus.

Authors:  J D Neill; S V Sosnovtsev; K Y Green
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Neutralizing epitopes of feline calicivirus.

Authors:  Y Tohya; K Masuoka; E Takahashi; T Mikami
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats.

Authors:  N Yokoyama; K Maeda; K Fujita; S Ishiguro; T Sagawa; M Mochizuki; Y Tohya; T Mikami
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.